Of the adult patients with EGPA that you have been personally responsible for treating and managing over the past 12 months, approximately how many are currently receiving pharmacological treatment specifically for their EGPA?# of patientsReceiving pharmacological treatment for their EGPANot receiving pharmacological treatment for their EGPAAcross all conditions you treat, not just EGPA, how many patients have you prescribed biologic treatment to over the past 12 months?Prescribed biologics to ______ patients over the past 12 monthsThank you!You qualify to take part in our survey focusing on patients with eosinophilic granulomatosis with polyangiitis (EGPA), and exploring your reactions to hypothetical new treatments that could become available in the future for these patients